Summit Therapeutics Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2024-09-26: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2024-09-11; Total offering amount $234,999,889.
- 2024-06-18: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2024-06-03; Total offering amount $199,999,998.
- 2020-11-23: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-11-06; Total offering amount $50,000,000.
- 2019-01-18: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-01-09; Total offering amount $25,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2024-09-26 | Rule 506(b) | Equity | 2024-09-11 | $234,999,889 | $234,999,889 | $0 | 17 |
|---|
| 2024-06-18 | Rule 506(b) | Equity | 2024-06-03 | $199,999,998 | $199,999,998 | $0 | 2 |
|---|
| 2020-11-23 | Rule 506(b) | Equity | 2020-11-06 | $50,000,000 | $50,000,000 | $0 | 3 |
|---|
| 2019-01-18 | Rule 506(b) | Equity | 2019-01-09 | $25,000,000 | $25,000,000 | $0 | 1 |
|---|
| 2014-03-04 | Rule 506(b) | Equity | 2014-03-04 | $11,644,000 | $11,644,000 | $0 | 13 |
|---|